MYD88 and hepatocellular carcinoma: To establish the level of expression of lnc-MyD88 in HCC, LC, and healthy subjects, the plasma levels of lnc-MyD88 were measured in all three groups, and the results illustrated in Figure 1A indicated a considerable upregulation of the lnc-MyD88 in patients with HCC compared with healthy subjects (P < 0.0001; Figure 1A).